Logo image of DXCM

DEXCOM INC (DXCM) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:DXCM - US2521311074 - Common Stock

73.92 USD
+1.81 (+2.51%)
Last: 1/22/2026, 10:17:36 PM
73.9 USD
-0.02 (-0.03%)
Pre-Market: 1/23/2026, 7:15:56 AM
Fundamental Rating

7

Taking everything into account, DXCM scores 7 out of 10 in our fundamental rating. DXCM was compared to 186 industry peers in the Health Care Equipment & Supplies industry. DXCM gets an excellent profitability rating and is at the same time showing great financial health properties. DXCM is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, DXCM could be worth investigating further for growth and quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • In the past year DXCM was profitable.
  • In the past year DXCM had a positive cash flow from operations.
  • DXCM had positive earnings in each of the past 5 years.
  • In the past 5 years DXCM always reported a positive cash flow from operatings.
DXCM Yearly Net Income VS EBIT VS OCF VS FCFDXCM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

  • The Return On Assets of DXCM (9.61%) is better than 93.01% of its industry peers.
  • With an excellent Return On Equity value of 26.44%, DXCM belongs to the best of the industry, outperforming 97.31% of the companies in the same industry.
  • DXCM has a Return On Invested Capital of 15.72%. This is amongst the best in the industry. DXCM outperforms 95.70% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for DXCM is above the industry average of 8.84%.
  • The 3 year average ROIC (11.25%) for DXCM is below the current ROIC(15.72%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.61%
ROE 26.44%
ROIC 15.72%
ROA(3y)7.95%
ROA(5y)8.21%
ROE(3y)23.2%
ROE(5y)22.06%
ROIC(3y)11.25%
ROIC(5y)9.23%
DXCM Yearly ROA, ROE, ROICDXCM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 -20 30

1.3 Margins

  • DXCM's Profit Margin of 15.96% is amongst the best of the industry. DXCM outperforms 92.47% of its industry peers.
  • DXCM's Profit Margin has improved in the last couple of years.
  • DXCM's Operating Margin of 18.41% is amongst the best of the industry. DXCM outperforms 90.32% of its industry peers.
  • In the last couple of years the Operating Margin of DXCM has grown nicely.
  • DXCM's Gross Margin of 60.20% is fine compared to the rest of the industry. DXCM outperforms 61.29% of its industry peers.
  • DXCM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 18.41%
PM (TTM) 15.96%
GM 60.2%
OM growth 3Y10.52%
OM growth 5Y8.87%
PM growth 3Y17.27%
PM growth 5Y15.84%
GM growth 3Y-3.98%
GM growth 5Y-0.72%
DXCM Yearly Profit, Operating, Gross MarginsDXCM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DXCM is still creating some value.
  • The number of shares outstanding for DXCM has been increased compared to 1 year ago.
  • DXCM has more shares outstanding than it did 5 years ago.
  • DXCM has a better debt/assets ratio than last year.
DXCM Yearly Shares OutstandingDXCM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
DXCM Yearly Total Debt VS Total AssetsDXCM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • DXCM has an Altman-Z score of 5.30. This indicates that DXCM is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of DXCM (5.30) is better than 77.42% of its industry peers.
  • The Debt to FCF ratio of DXCM is 2.36, which is a good value as it means it would take DXCM, 2.36 years of fcf income to pay off all of its debts.
  • DXCM has a better Debt to FCF ratio (2.36) than 85.48% of its industry peers.
  • DXCM has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of DXCM (0.47) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 2.36
Altman-Z 5.3
ROIC/WACC1.64
WACC9.61%
DXCM Yearly LT Debt VS Equity VS FCFDXCM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.56 indicates that DXCM should not have too much problems paying its short term obligations.
  • DXCM has a worse Current ratio (1.56) than 71.51% of its industry peers.
  • A Quick Ratio of 1.38 indicates that DXCM should not have too much problems paying its short term obligations.
  • DXCM has a worse Quick ratio (1.38) than 60.22% of its industry peers.
  • DXCM does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.38
DXCM Yearly Current Assets VS Current LiabilitesDXCM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

8

3. Growth

3.1 Past

  • DXCM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.41%, which is quite good.
  • DXCM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 29.25% yearly.
  • The Revenue has grown by 14.21% in the past year. This is quite good.
  • The Revenue has been growing by 22.27% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)9.41%
EPS 3Y35.38%
EPS 5Y29.25%
EPS Q2Q%35.56%
Revenue 1Y (TTM)14.21%
Revenue growth 3Y18.1%
Revenue growth 5Y22.27%
Sales Q2Q%21.64%

3.2 Future

  • DXCM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.05% yearly.
  • DXCM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.28% yearly.
EPS Next Y27.38%
EPS Next 2Y23.51%
EPS Next 3Y22.59%
EPS Next 5Y22.05%
Revenue Next Year15.38%
Revenue Next 2Y14.05%
Revenue Next 3Y13.59%
Revenue Next 5Y13.28%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DXCM Yearly Revenue VS EstimatesDXCM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
DXCM Yearly EPS VS EstimatesDXCM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3 4 5

5

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 39.74, DXCM can be considered very expensive at the moment.
  • DXCM's Price/Earnings ratio is a bit cheaper when compared to the industry. DXCM is cheaper than 70.43% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.30, DXCM is valued a bit more expensive.
  • A Price/Forward Earnings ratio of 29.37 indicates a quite expensive valuation of DXCM.
  • Based on the Price/Forward Earnings ratio, DXCM is valued a bit cheaper than 72.58% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.32. DXCM is valued slightly more expensive when compared to this.
Industry RankSector Rank
PE 39.74
Fwd PE 29.37
DXCM Price Earnings VS Forward Price EarningsDXCM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DXCM indicates a somewhat cheap valuation: DXCM is cheaper than 73.66% of the companies listed in the same industry.
  • 82.26% of the companies in the same industry are more expensive than DXCM, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 27.15
EV/EBITDA 24.66
DXCM Per share dataDXCM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • DXCM's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • The excellent profitability rating of DXCM may justify a higher PE ratio.
  • DXCM's earnings are expected to grow with 22.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.45
PEG (5Y)1.36
EPS Next 2Y23.51%
EPS Next 3Y22.59%

0

5. Dividend

5.1 Amount

  • DXCM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

DEXCOM INC / DXCM FAQ

Can you provide the ChartMill fundamental rating for DEXCOM INC?

ChartMill assigns a fundamental rating of 7 / 10 to DXCM.


Can you provide the valuation status for DEXCOM INC?

ChartMill assigns a valuation rating of 5 / 10 to DEXCOM INC (DXCM). This can be considered as Fairly Valued.


Can you provide the profitability details for DEXCOM INC?

DEXCOM INC (DXCM) has a profitability rating of 9 / 10.


Can you provide the PE and PB ratios for DXCM stock?

The Price/Earnings (PE) ratio for DEXCOM INC (DXCM) is 39.74 and the Price/Book (PB) ratio is 10.58.